Faculty by Area of Research
The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease, with an emphasis on respiratory, immune and related diseases.
Search by Name, Specialty, Program, or Research.
CAP15189SM Lab Accreditation One of Only 22 in Nation
Our Advanced Diagnostics Laboratories improve patient safety and reduce risk by outlining standards for quality and competence in medical laboratories. Read more about our accreditation.
Tucker Medical Library
Quality information for healthcare, education and scientific research. Learn more.
Targeting CYP11A1 in the Steroidogenic Pathway For Treating Allergic Diseases
Dr. Gelfand’s laboratory has identified CYP11A1 as a key regulator of allergic responses through its effect on steroidogenesis. Inhibition of CYP11A1 with aminoglutethimide in an animal model of either asthma or peanut allergy prevented an allergic response and the accumulation of inflammatory cells in a dose dependent manner. The therapeutic approach seen in asthma and peanut allergy could be applicable to other allergic diseases.
Technology Transfer Office
National Jewish Health supports academic and research activities across the campus and at outside organizations, including the University of Colorado Denver. Learn more.
We conduct clinical trials for patients with asthma, allergy, COPD, eczema, ILD, cystic fibrosis and more. Search All Clinical Trials.
Weinberg Clinical Research Unit
The Weinberg Clinical Research Unit focuses primarily on respiratory conditions. We entered the 21st century as the only institution in the world dedicated exclusively to this research of allergy, asthma, COPD/emphysema and sleep disorders as well as immune and autoimmune conditions, such as rheumatoid arthritis and cystic fibrosis. Learn more.